PST: Periosteal Stimulation for Knee Osteoarthritis
Study Details
Study Description
Brief Summary
185 veterans with chronic knee pain and advanced knee osteoarthritis will be recruited to participate in this study designed to test the effectiveness of a special type of electrical acupuncture called periosteal stimulation (PST). Participants will be divided into three groups. They will receive PST or a control condition once a week for 10 weeks. Two-thirds of the participants will receive booster sessions periodically over the course of the next 6 months. Everyone will be called monthly during the 6 month period and then will be asked to return for an evaluation on site at the end of this period.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
We have performed a promising initial trial of periosteal stimulation (PST, that is, electrical stimulation of 4 acupuncture needles around the knee that touch periosteum) as an analgesic for older veterans with advanced knee osteoarthritis (OA) and daily pain. The primary aim of the proposed trial is to optimize and sustain the efficacy of PST for reducing pain in veterans with advanced knee OA and unrelieved pain by combining it with booster PST. Our secondary aims are to 1) improve physical performance in these individuals, and 2) ascertain the physical and psychological predictors of response to PST. In a randomized controlled clinical trial, 180 veterans (age 50 and older) with persistent knee pain who have x-ray evidence of advanced OA will be assigned to one of three intervention groups: 1) control PST once a week for 10 weeks (i.e., needle placement with brief stimulation of non-periosteal needles), 2) PST once a week for 10 weeks followed by tapering PST boosters over 6 months, or 3) PST once a week for 10 weeks followed by tapering control-PST boosters over 6 months. Prior to initiating the intervention, immediately after the last session, and 6 months later, the following parameters will be assessed: 1) pain severity (WOMAC), 3) physical performance (gait velocity, stair climb, repetitive chair rise, timed up and go), and 4) psychological function (mood, coping, self-efficacy). Monthly telephone calls will assess pain, interim illness and physical activity.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: PST + PST boosters PST once a week for 10 weeks, then tapering over 6 months |
Other: Periosteal stimulation
Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.
|
Active Comparator: PST + control-PST boosters PST once a week for 10 weeks, then control-PST tapering over 6 months |
Other: Periosteal stimulation
Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute.
Other: Control-Periosteal Stimulation
Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.
|
Placebo Comparator: Control-PST control-PST for 10 weeks |
Other: Control-Periosteal Stimulation
Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute.
|
Outcome Measures
Primary Outcome Measures
- Pain (WOMAC) [9 months following baseline]
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales: Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome)
Eligibility Criteria
Criteria
Inclusion Criteria:
-
English speaking,
-
Knee pain on most days of the past 3 months that is more severe than pain in other parts of the lower body,
-
Advanced knee OA by x-ray,
-
age 50-89
Exclusion Criteria:
-
Non-ambulatory or severely impaired mobility (i.e., require the use of a walker),
-
Folstein MMSE < 24,
-
Severe uncorrected visual or hearing impairment,
-
Knee pain due to factors other than OA,
-
Large knee effusion,
-
History of corticosteroid or hyaluronic acid injection in the affected knee(s) during the preceding 3 months,
-
Acute or terminal illness,
-
Immune suppression,
-
Anticoagulation therapy,
-
Pacemaker,
-
Prior PST treatment
-
Active participation in other studies currently
-
Age >89
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Geriatric Research, Education, and Clinical Center | Pittsburgh | Pennsylvania | United States | 15206 |
Sponsors and Collaborators
- US Department of Veterans Affairs
Investigators
- Principal Investigator: Debra K. Weiner, MD, Geriatric Research, Education, and Clinical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- A6614-R
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Arm 1 | Arm 2 | Arm 3 |
---|---|---|---|
Arm/Group Description | PST once a week for 10 weeks, then tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. | PST once a week for 10 weeks, then control-PST tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. | control-PST for 10 weeks Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. |
Period Title: Overall Study | |||
STARTED | 63 | 64 | 63 |
COMPLETED | 57 | 59 | 62 |
NOT COMPLETED | 6 | 5 | 1 |
Baseline Characteristics
Arm/Group Title | Arm 1 | Arm 2 | Arm 3 | Total |
---|---|---|---|---|
Arm/Group Description | PST once a week for 10 weeks, then tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. | PST once a week for 10 weeks, then control-PST tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. | control-PST for 10 weeks Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. | Total of all reporting groups |
Overall Participants | 63 | 64 | 63 | 190 |
Age (years) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [years] |
67.1
(8.9)
|
65.8
(8.7)
|
66.8
(10.4)
|
66.5
(9.3)
|
Sex: Female, Male (Count of Participants) | ||||
Female |
8
12.7%
|
10
15.6%
|
11
17.5%
|
29
15.3%
|
Male |
55
87.3%
|
54
84.4%
|
52
82.5%
|
161
84.7%
|
Ethnicity (NIH/OMB) (Count of Participants) | ||||
Hispanic or Latino |
2
3.2%
|
0
0%
|
0
0%
|
2
1.1%
|
Not Hispanic or Latino |
61
96.8%
|
64
100%
|
63
100%
|
188
98.9%
|
Unknown or Not Reported |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Race (NIH/OMB) (Count of Participants) | ||||
American Indian or Alaska Native |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Asian |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Native Hawaiian or Other Pacific Islander |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Black or African American |
18
28.6%
|
22
34.4%
|
16
25.4%
|
56
29.5%
|
White |
45
71.4%
|
42
65.6%
|
47
74.6%
|
134
70.5%
|
More than one race |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Unknown or Not Reported |
0
0%
|
0
0%
|
0
0%
|
0
0%
|
Region of Enrollment (participants) [Number] | ||||
United States |
63
100%
|
64
100%
|
63
100%
|
190
100%
|
WOMAC (units on a scale) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [units on a scale] |
9.0
(3.2)
|
9.9
(4.0)
|
10.6
(3.6)
|
9.8
(3.6)
|
Short Physical Performance Battery (units on a scale) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [units on a scale] |
6.1
(1.8)
|
6.1
(1.9)
|
6.2
(1.5)
|
6.1
(1.7)
|
Timed stair climb (seconds) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [seconds] |
12.5
(4.7)
|
14.5
(7.8)
|
13.9
(7.3)
|
13.6
(6.6)
|
Timed Up and Go (seconds) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [seconds] |
12.3
(3.4)
|
13.1
(3.8)
|
13.9
(6.9)
|
13.1
(4.7)
|
CES-D (units on a scale) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [units on a scale] |
11.7
(10.3)
|
14.7
(11.2)
|
12.3
(9.6)
|
12.9
(10.4)
|
Cognitive Strategies Questionnaire, catastrophizing scale (units on a scale) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [units on a scale] |
7.9
(7.8)
|
12.1
(9.7)
|
8.8
(9.2)
|
9.6
(8.9)
|
BMI (kg/m2) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [kg/m2] |
31.6
(6.5)
|
33.1
(6.2)
|
32.5
(6.9)
|
32.4
(6.5)
|
Mean number of pain medications (medication) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [medication] |
1.1
(1.0)
|
1.2
(0.9)
|
1.0
(0.9)
|
1.1
(0.9)
|
Mean number of opioids (opioids) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [opioids] |
0.1
(0.3)
|
0.3
(0.6)
|
0.2
(0.4)
|
0.2
(0.4)
|
Duration of knee pain (years) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [years] |
5.7
(6.4)
|
6.2
(6.8)
|
7.2
(8.3)
|
6.4
(7.2)
|
Arthritis Self-Efficacy score, pain (units on a scale) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [units on a scale] |
64.3
(21.6)
|
59.5
(22.6)
|
63.9
(21.7)
|
62.6
(22)
|
Arthritis Self-Efficacy score, function (units on a scale) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [units on a scale] |
77.5
(17.0)
|
76.3
(16.9)
|
76.1
(16.4)
|
76.6
(16.8)
|
Arthritis Self-Efficacy score, other symptoms (units on a scale) [Mean (Standard Deviation) ] | ||||
Mean (Standard Deviation) [units on a scale] |
70.5
(21.1)
|
65.9
(20.3)
|
68.6
(20.9)
|
68.3
(20.8)
|
Outcome Measures
Title | Pain (WOMAC) |
---|---|
Description | The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) consists of 24 items divided into 3 subscales: Pain (5 items), score range 0-20 Stiffness (2 items): score range 0-8 Physical Function (17 items): score range 0-68 Total score ranges from 0 (best possible outcome) to 96 (worst possible outcome) |
Time Frame | 9 months following baseline |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Arm 1 | Arm 2 | Arm 3 |
---|---|---|---|
Arm/Group Description | PST once a week for 10 weeks, then tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. | PST once a week for 10 weeks, then control-PST tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. | control-PST for 10 weeks Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. |
Measure Participants | 57 | 59 | 62 |
Mean (Standard Error) [units on a scale] |
6.1
(3.5)
|
6.6
(3.6)
|
7.9
(7.7)
|
Adverse Events
Time Frame | ||||||
---|---|---|---|---|---|---|
Adverse Event Reporting Description | ||||||
Arm/Group Title | Arm 1 | Arm 2 | Arm 3 | |||
Arm/Group Description | PST once a week for 10 weeks, then tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. | PST once a week for 10 weeks, then control-PST tapering over 6 months Periosteal stimulation: Four acupuncture needles are placed around the knee to the level of the periosteum and two needles are placed pretibially in the soft tissue. All needles are stimulated with 100 Hz current. The stimulation of the needles in the soft tissue is discontinued after one minute. Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. | control-PST for 10 weeks Control-Periosteal Stimulation: Acupuncture needles are placed as per the PST intervention, but only the soft tissue needles receive electrical stimulation for one minute. | |||
All Cause Mortality |
||||||
Arm 1 | Arm 2 | Arm 3 | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | / (NaN) | / (NaN) | / (NaN) | |||
Serious Adverse Events |
||||||
Arm 1 | Arm 2 | Arm 3 | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 3/63 (4.8%) | 1/64 (1.6%) | 1/63 (1.6%) | |||
Cardiac disorders | ||||||
Myocardial Infarction | 1/63 (1.6%) | 1 | 0/64 (0%) | 0 | 0/63 (0%) | 0 |
Gastrointestinal disorders | ||||||
Bowel obstruction | 1/63 (1.6%) | 1 | 0/64 (0%) | 0 | 0/63 (0%) | 0 |
General disorders | ||||||
Death | 1/63 (1.6%) | 1 | 0/64 (0%) | 0 | 0/63 (0%) | 0 |
Infections and infestations | ||||||
abscess | 0/63 (0%) | 0 | 1/64 (1.6%) | 1 | 0/63 (0%) | 0 |
Respiratory, thoracic and mediastinal disorders | ||||||
Dyspnea | 0/63 (0%) | 0 | 0/64 (0%) | 0 | 1/63 (1.6%) | 1 |
Other (Not Including Serious) Adverse Events |
||||||
Arm 1 | Arm 2 | Arm 3 | ||||
Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | Affected / at Risk (%) | # Events | |
Total | 3/63 (4.8%) | 0/64 (0%) | 1/63 (1.6%) | |||
General disorders | ||||||
sweating | 0/63 (0%) | 0 | 0/64 (0%) | 0 | 0/63 (0%) | 0 |
Lightheaded | 1/63 (1.6%) | 1 | 0/64 (0%) | 0 | 0/63 (0%) | 0 |
Musculoskeletal and connective tissue disorders | ||||||
Pain | 1/63 (1.6%) | 1 | 0/64 (0%) | 0 | 1/63 (1.6%) | 1 |
Skin and subcutaneous tissue disorders | ||||||
Bruising | 1/63 (1.6%) | 1 | 0/64 (0%) | 0 | 0/63 (0%) | 0 |
Limitations/Caveats
More Information
Certain Agreements
All Principal Investigators ARE employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr. Debra K. Weiner |
---|---|
Organization | VA Pittsburgh Healthcare System |
Phone | 412-360-2920 |
debra.weiner@va.gov |
- A6614-R